Racial‒Ethnic Disparities of Buprenorphine and Vivitrol Receipt in Medicaid

This publication has 16 references indexed in Scilit:

• Addressing racial & socioeconomic disparities in access to medications for opioid use disorder amid COVID-19
  Journal of Substance Abuse Treatment, 2021
• Trends and Geographic Patterns in Drug and Synthetic Opioid Overdose Deaths — United States, 2013–2019
  MMWR. Morbidity and Mortality Weekly Report, 2021
• Drug Overdose Deaths Head Toward Record Number in 2020, CDC Warns
  JAMA Health Forum, 2020
• Association of Racial/Ethnic Segregation With Treatment Capacity for Opioid Use Disorder in Counties in the United States
  JAMA Network Open, 2020
• Trends in Buprenorphine Treatment in the United States, 2009-2018
  JAMA, 2020
• Buprenorphine Treatment Divide by Race/Ethnicity and Payment
  JAMA Psychiatry, 2019
• Nurse Practitioner and Physician Assistant Waivers to Prescribe Buprenorphine and State Scope of Practice Restrictions
  JAMA, 2019
• Management of opioid use disorder in the USA: present status and future directions
  The Lancet, 2019
• Policy Pathways to Address Provider Workforce Barriers to Buprenorphine Treatment
  American Journal of Preventive Medicine, 2018
• Methadone as Social Control
  Qualitative Health Research, 2012